PROCEPT BioRobotics Corporation
NASDAQPROCEPT BioRobotics heads into the post-earnings stretch with analysts slashing price targets and the stock trading at $18.28 — down 13% over the past month and sitting well below where most of the Street was positioned just weeks ago. The analyst reaction has been swift and broad. TD Cowen trimmed its target from $34 to $28 on August 5, while Piper Sandler cut from $35 to $25 and…
PRCT cost to borrow surges to 0.446%, up 111% over one week, as short interest holds at 12.3% of float.
Snapshot as of 5 Aug 2026
PROCEPT BioRobotics heads into the post-earnings stretch with analysts slashing price targets and the stock trading at $18.28 — down 13% over the past month and sitting well below where most of the Street was…
PROCEPT BioRobotics enters the week of June 23 with a fresh analyst initiation pulling against a stock that has lost nearly 29% in a month — a classic tug-of-war between fundamental conviction and deteriorating price…
Short interest updated daily, real-time options flow, analyst consensus deltas, 13F positioning, ORTEX Alpha signals, and every article ORTEX publishes for PRCT — free to start on ORTEX.
Sign up for free →Open PRCT on ORTEX